# Northwest Biotherapeutics Inc: Form 8-K, filed Apr 7, 2026

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2026-04-07
- Accepted by EDGAR: Apr 7, 2026, 12:30 ET
- Period: 2025-10-24
- Accession: 0001104659-26-040260
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465926040260/tm2611284d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465926040260/

## Items reported

- Item 2.01: Completion of an acquisition or disposition

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465926040260/tm2611284d1_8k.htm

Filed Apr 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-040260. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.